Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9
Corrigendum
Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin’s lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,064 | Dovepress* | 7,822+ | 1,684 | 9,506 | |
| PubMed Central* | 242 | 124 | 366 | ||
| Totals | 8,064 | 1,808 | 9,872 | ||
| *Since 17 January 2017 | |||||
View citations on PubMed Central and Google Scholar